Table 2 Analysis of the clinical characteristics before first use of vascular access according to vascular access type
Total (N = 529) | RC AVF (N = 264) | BC AVF (N = 168) | AVG (N = 97) | P | ||
|---|---|---|---|---|---|---|
CVC | None | 227 (42.9) | 121 (45.8) | 69 (41.1) | 37 (38.1) | 0.358 |
IJC | 3 (0.6) | 2 (0.8) | 0 (0) | 1 (1.0) | ||
Permanent catheter | 299 (56.5) | 141 (53.4) | 99 (58.9) | 59 (60.0) | ||
CVC duration (days) | 113.4 ± 73.5 | 115.3 ± 68.7 | 112.7 ± 63.7 | 109.3 ± 101.4 | 0.891 | |
Preoperative surveillance | None | 192 (36.4) | 123 (46.8) | 53 (31.5) | 16 (16.5) | < 0.001 |
Duplex ultrasonography | 207 (39.2) | 102 (38.8) | 85 (50.6) | 20 (20.6) | ||
Venography | 60 (11.4) | 17 (6.5) | 19 (13.3) | 24 (24.7) | ||
Both | 69 (13.1) | 21 (8.0) | 11 (6.5) | 37 (38.1) | ||
Time to 1st use (days) | 64.0 (14.0–124.0) | 75.0 (12.0–138.0) | 65.5 (8.8–122.3) | 35.0 (5.0–65.0) | 0.001 | |
PTA before maturation | 112 (21.2) | 70 (26.5) | 27 (16.1) | 15 (15.5) | 0.011 | |